Zobrazeno 1 - 6
of 6
pro vyhledávání: '"R. B. Heuschkel"'
Publikováno v:
Archives of Disease in Childhood. 91:426-432
Twenty five per cent of inflammatory bowel disease presents in childhood. Growth and nutrition are key issues in the management with the aim of treatment being to induce and then maintain disease remission with minimal side effects. Only 25% of Crohn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13698319afc43d8da67047034f1a4a63
https://doi.org/10.1136/adc.2005.080481
https://doi.org/10.1136/adc.2005.080481
Autor:
Sylvia L.F. Pender, J. A. W. Smith, R. B. Heuschkel, Mona Bajaj-Elliott, T T MacDonald, Giovanni Monteleone
Publikováno v:
Gut. 47:57-62
BACKGROUND—Degradation of the extracellular matrix and ulceration of the mucosa are major features of inflammatory bowel disease (IBD). One of the most important enzymes in degrading the matrix and produced in excess by cytokine activated stromal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d22788d899dfcef323cc10180ebee9
https://doi.org/10.1136/gut.47.1.57
https://doi.org/10.1136/gut.47.1.57
Autor:
R K, Russell, M L, Wilson, S, Loganathan, B, Bourke, F, Kiparissi, G, Mahdi, F, Torrente, A, Rodrigues, I, Davies, A, Thomas, A K, Akobeng, A, Fagbemi, W, Hyer, C, Spray, S, Vaish, P, Rogers, P, McGrogan, R B, Heuschkel, N, Ayub, J M, Fell, N A, Afzal, M, Green, M S, Murphy, P, Rao, N, Shah, G-T, Ho, S, Naik, D C, Wilson
Publikováno v:
Alimentary pharmacologytherapeutics. 33(8)
Adalimumab is efficacious therapy for adults with Crohn's disease (CD).To summarise the United Kingdom and Republic of Ireland paediatric adalimumab experience.British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) members
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2f6fa1c3a8b478fe20a195c64dc9696
https://pubmed.ncbi.nlm.nih.gov/21342211
https://pubmed.ncbi.nlm.nih.gov/21342211
Autor:
D, Fuentes, F, Torrente, S, Keady, K, Thirrupathy, M A, Thomson, J A, Walker-Smith, S H, Murch, R B, Heuschkel
Publikováno v:
Alimentary pharmacologytherapeutics. 17(7)
Azathioprine is widely used as maintenance therapy in children with moderate to severe inflammatory bowel disease (IBD). There is no data on safety at higher doses and its impact on growth and surgical morbidity in children.This retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc92f8a145b8190b4d96be1e6de33322
https://pubmed.ncbi.nlm.nih.gov/12656694
https://pubmed.ncbi.nlm.nih.gov/12656694
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition. 39:S310-S311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d89105dd65e0f3cade27cdf9c9aca61
https://doi.org/10.1097/00005176-200406001-00791
https://doi.org/10.1097/00005176-200406001-00791
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 26:548
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c8e203a1dbf246bcdc9fa753a62a1a8
https://doi.org/10.1097/00005176-199805000-00059
https://doi.org/10.1097/00005176-199805000-00059